Body mass index is associated with leukotriene inflammation in asthmatics

European Journal of Clinical Investigation

Volumn 41, Issue 1, 2011, Pages 30-38

  Giouleka, Paschalina ^a   Papatheodorou, Georgios ^b   Lyberopoulos, Panagiotis ^a   Karakatsani, Anna ^a   Alchanatis, Manos ^a   Roussos, Charis ^a   Papiris, Spyros ^a   Loukides, Stelios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b 401 GENERAL MILITARY HOSPITAL OF ATHENS   (Greece)

Author keywords

Adipose tissue; Asthma; Inflammation; Leukotrienes; Obesity

Indexed keywords

ADIPONECTIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CREATININE; LEPTIN; LEUKOTRIENE; OMALIZUMAB; STEROID;

ADULT; ARTICLE; ASTHMA; BODY MASS; COMORBIDITY; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE ASSOCIATION; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL;

ADIPONECTIN; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASTHMA; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATION; LEPTIN; LEUKOTRIENES; MALE; MIDDLE AGED; OBESITY; YOUNG ADULT;

EID: 78650052167     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02371.x     Document Type: Article

References (39)

1. Matricardi PM, Gruber C, Wahn U, Lau S. The asthma-obesity link in childhood: open questions, complex evidence, a few answers only. Clin Exp Allergy 2007;37:476-84.
2. Shore SA, Johnston RA. Obesity and asthma. Pharmacol Ther 2006;110:83-102.
3. Lessard A, Turcotte H, Cormier Y, Boulet LP. Obesity and asthma: a specific phenotype? Chest 2008;134:317-23.
4. Peters-Golden M, Swern A, Bird SS, Hustad CM, Grant E, Edelman JM. Influence of body mass index on the response to asthma controller agents. Eur Respir J 2006;27:495-503.
5. Shore SA. Obesity and asthma: possible mechanisms. J Allergy Clin Immunol 2008;121:1087-93; quiz 94-5.
6. Sutherland TJ, Cowan JO, Young S, Goulding A, Grant AM, Williamson A et al. The association between obesity and asthma: interactions between systemic and airway inflammation. Am J Respir Crit Care Med 2008;178:469-75.
7. Van Veen IH, Ten Brinke A, Sterk PJ, Rabe KF, Bel EH. Airway inflammation in obese and nonobese patients with difficult-to-treat asthma. Allergy 2008;63:570-4.
8. Juge-Aubry CE, Henrichot E, Meier CA. Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metab 2005;19:547-66.
9. Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta 2007;380:24-30.
10. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31:143-78.
11. Boulet LP. Influence of comorbid conditions on asthma. Eur Respir J 2009;33:897-906.
12. Higashi N, Taniguchi M, Mita H, Ishii T, Akiyama K. Nasal blockage and urinary leukotriene E4 concentration in patients with seasonal allergic rhinitis. Allergy 2003;58:476-80.
13. Higashi N, Taniguchi M, Mita H, Kawagishi Y, Ishii T, Higashi A et al. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): involvement of chronic hyperplastic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol 2004;113:277-83.
14. Higashi N, Taniguchi M, Mita H, Osame M, Akiyama K. A comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin-intolerant asthma. Clin Exp Allergy 2002;32:1484-90.
15. Vardavas CI, Linardakis MK, Hatzis CM, Saris WH, Kafatos AG. Prevalence of obesity and physical inactivity among farmers from Crete (Greece), four decades after the Seven Countries Study. Nutr Metab Cardiovasc Dis 2009;19:156-62.
16. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010;40:35-53.
17. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:i-xii, 1-253.
18. American Thoracic Society and European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005;171:912-30.
19. Menzies D, Nair A, Lipworth BJ. Portable exhaled nitric oxide measurement: comparison with the "gold standard" technique. Chest 2007;131:410-4.
20. Horvath I, Hunt J, Barnes PJ, Alving K, Antczak A, Baraldi E et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005;26:523-48.
21. Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med 1995;152:1107-36.
22. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000;161:309-29.
23. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004;113:59-65.
24. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med 2000;162:2341-51.
25. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22:667-89.
26. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5.
27. Gaki E, Papatheodorou G, Ischaki E, Grammenou V, Papa I, Loukides S. Leukotriene E(4) in urine in patients with asthma and COPD - the effect of smoking habit. Respir Med 2007;101:826-32.
28. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
29. Mancuso P, Gottschalk A, Phare SM, Peters-Golden M, Lukacs NW, Huffnagle GB. Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. J Immunol 2002;168:4018-24.
30. Mancuso P, Canetti C, Gottschalk A, Tithof PK, Peters-Golden M. Leptin augments alveolar macrophage leukotriene synthesis by increasing phospholipase activity and enhancing group IVC iPLA2 (cPLA2gamma) protein expression. Am J Physiol Lung Cell Mol Physiol 2004;287:L497-L502.
31. Cederholm T, Lindgren JA, Palmblad J. Impaired leukotriene C4 generation in granulocytes from protein-energy malnourished chronically ill elderly. J Intern Med 2000;247:715-22.
32. Loerbroks A, Apfelbacher CJ, Amelang M, Sturmer T. Obesity and adult asthma: potential effect modification by gender, but not by hay fever. Ann Epidemiol 2008;18:283-9.
33. Appleton SL, Adams RJ, Wilson DH, Taylor AW, Ruffin RE. Central obesity is associated with nonatopic but not atopic asthma in a representative population sample. J Allergy Clin Immunol 2006;118:1284-91.
34. Sutherland ER, Goleva E, Strand M, Beuther DA, Leung DY. Body mass and glucocorticoid response in asthma. Am J Respir Crit Care Med 2008;178:682-7.
35. Shore SA, Schwartzman IN, Mellema MS, Flynt L, Imrich A, Johnston RA. Effect of leptin on allergic airway responses in mice. J Allergy Clin Immunol 2005;115:103-9.
36. Shore SA, Terry RD, Flynt L, Xu A, Hug C. Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. J Allergy Clin Immunol 2006;118:389-95.
37. Jartti T, Saarikoski L, Jartti L, Lisinen I, Jula A, Huupponen R et al. Obesity, adipokines and asthma. Allergy 2009;64:770-7.
38. Sutherland TJ, Sears MR, McLachlan CR, Poulton R, Hancox RJ. Leptin, adiponectin, and asthma: findings from a population-based cohort study. Ann Allergy Asthma Immunol 2009;103:101-7.
39. Kattan M, Kumar R, Bloomberg GR, Mitchell HE, Calatroni A, Gergen PJ et al. Asthma control, adiposity, and adipokines among inner-city adolescents. J Allergy Clin Immunol 2010;125:584-92.